The solid organ transplant recipient with SARS-CoV-2 infection

Area of Science:

• Infectious Diseases
• Transplant Medicine
• Public Health

Background:

• The COVID-19 pandemic presents a global health challenge, disproportionately affecting vulnerable groups.
• Solid organ transplant (SOT) recipients represent a key vulnerable population requiring specific consideration.
• Understanding COVID-19 epidemiology and treatment in SOT recipients is critical.

Purpose of the Study:

• To review the emerging epidemiology of COVID-19 in SOT recipients.
• To discuss current treatment options for COVID-19 relevant to SOT patients.
• To highlight the implications of existing knowledge for SOT recipients.

Main Methods:

• Review of emerging epidemiological data on COVID-19.
• Analysis of available treatment options for COVID-19.
• Discussion of implications for solid organ transplant recipients.

Main Results:

• COVID-19 outcomes in SOT recipients appear similar to the general population, though data are still emerging.
• Reports of donor-derived SARS-CoV-2 infection are increasing.
• Limited studies exist on specific COVID-19 treatments for SOT recipients; general recommendations apply.
• Vaccine efficacy in the SOT population is currently uncertain.

Conclusions:

• COVID-19 remains a substantial risk for SOT recipients.
• Urgent research into COVID-19 treatment and prevention tailored for SOT recipients is needed.
• The efficacy of COVID-19 vaccines in this immunocompromised population requires further investigation.